Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
CME/CE Information is available within the activity.
Webinar | Primary Care | 0.25 - 15 mins | Internal Medicine | Rheumatology | Family Medicine | Nurse | Nurse Practitioner | Endocrinology | No Longer Available for Credit |
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA